The CMED Council of Ministers approved three levels of adjustment: 10.08%; 8.44%; and 6.79%, which vary according to the competitiveness of the brands in the market.
The annual readjustment in the medication sector happens, generally, in April. Last year, however, the government suspended the increases for 60 days due to the covid-19 pandemic.
The percentage of increase is defined in accordance with Law 10.742 / 2003 and calculated using a formula that takes into account the variation in inflation – measured by the Broad National Consumer Price Index (IPCA) -, productivity gains of drug manufacturers, variation in input costs and market characteristics. From March 2020 to February 2021, the IPCA accumulated an increase of 5.20%.
In addition, CMED also sets the maximum consumer price in each state, according to the ICMS tax burden, which is state tax, and the incidence of PIS / Pasep contributions (Social Integration Program and Heritage Formation Program) of Public Servants) and Cofins (Contribution for the Financing of Social Security), which are federal taxes. To be entitled to the price readjustment, companies that produce and import medicines should submit a marketing report to CMED by April 9th.
Companies should also publicize widely the prices of their medicines and pharmacies should keep the lists of updated values available to consumers and supervisory bodies.
Get the latest news delivered to your inbox
Follow us on social media networks